Testing a protective solution for donated kidneys
Treatments studied
Part of Kidney & urinary clinical trials.
This study tests a special solution given to the donor kidney during storage and transport, which may help protect the kidney before transplant. It is for adults with kidney failure receiving a deceased donor kidney.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have end-stage renal disease (kidney failure).
- You are scheduled to receive a kidney from a deceased donor (someone who has passed away).
- You cannot be pregnant.
- You cannot have a known allergy to the study medication (thiosulfate) or its ingredients.
- You cannot be receiving a multi-organ transplant (like kidney-pancreas) or a living donor kidney.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special cold storage solution and machine to keep donated kidneys healthy before they are transplanted. It may help the kidneys work better after surgery.
This trial tests a blood test that may help monitor kidney transplant health by detecting signs of rejection earlier. It aims to see if using this blood test can lead to better long-term outcomes for transplant recipients.
This study looks at whether testing the fluid used to store donated organs can help doctors find and treat infections earlier, possibly leading to better outcomes after a liver or kidney transplant.
This study is testing a new way to help the body accept a kidney transplant without needing lifelong anti-rejection drugs. It involves transplanting a small piece of the donor's thymus (a gland that helps the immune system) along with the kidney, to train the body to see the new kidney as part of itself.
This study tests whether giving a special mix of donor immune cells along with immune-suppressing medicines right after a kidney transplant can help the body accept the new kidney without long-term anti-rejection drugs. It aims to reduce the need for daily transplant medications.
This trial tests a new liquid treatment (iCM012) that is applied to a donor kidney before transplantation. The goal is to improve how well the kidney works after it is transplanted.
Hear when a new Renal Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.